
### [MONDO:0020190](http://purl.obolibrary.org/obo/MONDO_0020190)
**Label:** eyebrow/eyelashes distichiasis

**Subclasses:** [MONDO:0007922](http://purl.obolibrary.org/obo/MONDO_0007922) (lymphedema-distichiasis syndrome), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0007464](http://purl.obolibrary.org/obo/MONDO_0007464) (isolated distichiasis), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0018071](http://purl.obolibrary.org/obo/MONDO_0018071) (trisomy 18), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0090050](http://purl.obolibrary.org/obo/GO_0090050) (positive regulation of cell migration involved in sprouting angiogenesis), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0033625](http://purl.obolibrary.org/obo/GO_0033625) (positive regulation of integrin activation), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0072144](http://purl.obolibrary.org/obo/GO_0072144) (glomerular mesangial cell development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0035470](http://purl.obolibrary.org/obo/GO_0035470) (positive regulation of vascular wound healing), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0072011](http://purl.obolibrary.org/obo/GO_0072011) (glomerular endothelium development), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0048343](http://purl.obolibrary.org/obo/GO_0048343) (paraxial mesodermal cell fate commitment), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 53.99%
- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 51.28%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 37.49%
- [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031909](http://purl.obolibrary.org/obo/GO_0031909) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031888](http://purl.obolibrary.org/obo/GO_0031888) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031794](http://purl.obolibrary.org/obo/GO_0031794) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031793](http://purl.obolibrary.org/obo/GO_0031793) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031792](http://purl.obolibrary.org/obo/GO_0031792) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031791](http://purl.obolibrary.org/obo/GO_0031791) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031790](http://purl.obolibrary.org/obo/GO_0031790) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031744](http://purl.obolibrary.org/obo/GO_0031744) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031743](http://purl.obolibrary.org/obo/GO_0031743) (null)) 36.64%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:0031742](http://purl.obolibrary.org/obo/GO_0031742) (null)) 36.64%


